(Q53213556)

12 May 2018

title

Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T? (English)

1 reference

12 May 2018

1 reference

5

Tone F Bathen

1 reference

12 May 2018

Ingrid Susann Gribbestad

series ordinal

4

object named as

Ingrid S Gribbestad

1 reference

12 May 2018

2

Steinar Lundgren

1 reference

12 May 2018

1

Mariann G Heldahl

1 reference

12 May 2018

author name string

Line R Jensen

series ordinal

3

1 reference

12 May 2018

publication date

14 July 2011

1 reference

12 May 2018

Journal of Magnetic Resonance Imaging

published in

1 reference

12 May 2018

volume

34

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

547-556

1 reference

12 May 2018

Neoadjuvant therapy for breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Application of magnetic resonance imaging to angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Model-based and model-free parametric analysis of breast dynamic-contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Lesion T(2) relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

A review of MR physics: 3T versus 1.5T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Analysis of cardiac function--comparison between 1.5 Tesla and 3.0 Tesla cardiac cine magnetic resonance imaging: preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Clinical 1H magnetic resonance spectroscopy of brain metastases at 1.5T and 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Advances in functional and structural MR image analysis and implementation as FSL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

A comparison of two methods for measuring the signal to noise ratio on MR images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Predictive markers of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22642

21 January 2018

Identifiers

DOI

10.1002/JMRI.22642

1 reference

12 May 2018

1 reference

12 May 2018